←back to thread

275 points swores | 1 comments | | HN request time: 0s | source
Show context
FredPret ◴[] No.40173118[source]
Drugs may be overpriced.

There is probably some bloat in drug development. But then again, maybe not. I'm not an expert.

What I do know is that drugs have gotten dramatically better in the short amount of time I've been alive.

The other thing we all know is that the source of this article, The Guardian and their friends, have a shitlist of industries and institutions it loves to hate.

Ask yourself: will they ever write a positive article about a defense contractor, a bank, big pharma, a US billionaire, or a landlord, even if said entity walks on water and then saves a million babies and the penguins and the world?

replies(4): >>40173169 #>>40173184 #>>40173519 #>>40173529 #
CogitoCogito ◴[] No.40173184[source]
> What I do know is that drugs have gotten dramatically better in the short amount of time I've been alive.

How do you know this? How do you measure “better”? Something like QOL improvement per dollar? Have you done (or read) some large study on this or something?

replies(3): >>40173239 #>>40173249 #>>40173270 #
zer00eyz ◴[] No.40173239[source]
Were curing forms of cancer that would have killed you decades ago.

HIV, in my life time was a death sentence. Now people are living almost full lives.

Less dead people is a pretty good metric for drug development.

replies(3): >>40173333 #>>40173372 #>>40174682 #
1. cal5k ◴[] No.40173372[source]
You forgot to mention that we can now effectively "cure" obesity with GLP-1 receptor agonists.

Oh, and as a nice little bonus they also curb substance use disorder!